IF OUR local MP Chester Borrows had wanted an honest, robust debate on the merits of the TPP and its alleged benefits nationally and locally, that would have been OK. But his defence of TPP (Chronicle, October 9) is anything but that. I recognise that Mr Borrows has got to make some kind of sales pitch in support of leader John Key's TPP. If you take the leader's ministerial limousine, you must be willing to do Mr Key's bidding.
Chester can and does inventory accurately the number of jobs currently active in our regional industries. It's the promise of more jobs due to the TPP which has no basis in reality and which serious critics dispute, claiming that TPP will actually enable more jobs to go offshore.
What's even less debatable and amounts to what the American comedian calls "truthiness" is Borrows' claims about the minimally increased cost of medications due to implementation of the TPP. Chester says: "We know the cost of prescriptions won't increase."
He claims the expected increased cost of medications is $2.2 million and easily covered by the expected increase to our GDP from the trade deal. This flawed statement reminds me of the Bush administration assurance that invading Iraq would cost $50 billion and be paid for by Iraqi oil. It's make-believe math and make-a-wish economics.
MOH gives the current annual cost of medication to New Zealanders as $2 billion (1 per cent of GDP). It's been increasing by 5 per cent annually since 2006. That's 100 million annual increase before TPP. Mr Borrows' number, $2.2 million for the added cost due to TPP, is an 0.1 per cent increase. A very optimistic estimate would be an additional $100 million. It's much more likely to double our current costs, adding $2 billion to medication costs alone.